|1|Significance of TP53 mutations determined by next-generation "deep" sequencing in prognosis of estrogen receptor-positive breast cancer. (23973262)
Uji K.... Noguchi S.
|2|Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer. (23205744)
Bjerre C.... Laenkholm A.V.
|3|The financial burden of using Oncotype Dx for patients with lymph node-negative and estrogen receptor-positive breast cancer in Australia. (23718901)
Sakata S.... Cronk M.
|4|Metastasis dormancy in estrogen receptor-positive breast cancer. (24298069)
Zhang X.H.... Osborne C.K.
|5|A Common Variant in the SIAH2 Locus Is Associated with Estrogen Receptor-Positive Breast Cancer in the Chinese Han Population. (24244489)
Zhang B.... Chen Z.
|6|Functional variable number of tandem repeats variation in the promoter of proto-oncogene PTTG1IP is associated with risk of estrogen receptor-positive breast cancer. (22404099)
Xiang C.... Wang H.
|7|Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients. (21796367)
van Nes J.G.... Bartlett J.M.
|8|9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium. (22859399)
Warren H.... dos-Santos-Silva I.
|9|Regulation of fatty acid synthase (FAS) and apoptosis in estrogen-receptor positive and negative breast cancer cells by conjugated linoleic acids. (23142364)
Song H.J.... Wahle K.W.
|10|Polyendocrine treatment in estrogen receptor-positive breast cancer: a "FACT" yet to be proven. (22547606)
Di Leo A.... Malorni L.
|11|Estrogen-mediated upregulation of Noxa is associated with cell cycle progression in estrogen receptor-positive breast cancer cells. (22216287)
Liu W.... Das G.M.
|12|Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer. (22021667)
Monsees G.M.... Li C.I.
|13|PRO_10--a new tissue-based prognostic multigene marker in patients with early estrogen receptor-positive breast cancer. (21613801)
Moor A.E.... Aebi S.
|14|Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer. (20535543)
Zhao Y.... Xiao G.G.
|15|Activity of taspine isolated from Radix et Rhizoma Leonticis against estrogen-receptor-positive breast cancer. (21605638)
Zhan Y.... He L.
|16|Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers. (21310761)
Park S.... Lee K.S.
|17|CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (A+)-14,15-epoxyeicosatrienoic acid (EET). (21402692)
Mitra R.... Potter D.A.
|18|Shift in cytotoxic target from estrogen receptor-positive to estrogen receptor-negative breast cancer cells by trastuzumab in combination with taxane-based chemotherapy. (22866081)
Hayashi M.... Nishimura R.
|19|Estrogen regulated expression of the p21 Waf1/Cip1 gene in estrogen receptor positive human breast cancer cells. (20301197)
Mandal S.... Davie J.R.
|20|Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy]. (21029696)
Wang S.L.... Yu Z.H.
|21|Microarray data analysis in neoadjuvant biomarker studies in estrogen receptor-positive breast cancer. (20804563)
Luo J.... Ellis M.J.
|22|Vascular endothelial growth factor secreted by activated stroma enhances angiogenesis and hormone-independent growth of estrogen receptor-positive breast cancer. (20332242)
Pinto M.P.... Horwitz K.B.
|23|A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer. (19941160)
McCaig F.M.... Dixon J.M.
|24|Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer. (18340528)
Rody A.... Kaufmann M.
|25|Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. (19567422)
Milne R.L.... Easton D.F.
|26|Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer. (19920189)
Frasor J.... Stanculescu A.
|27|Androgen-induced human breast cancer cell proliferation is mediated by discrete mechanisms in estrogen receptor-alpha-positive and -negative breast cancer cells. (19159686)
Lin H.Y.... Davis P.J.
|28|Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines. (19171042)
Tan H.... Pan Z.
|29|A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study. (18771580)
Novelli F.... Mottolese M.
|30|Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics. (18812550)
Ellis M.J.... Dowsett M.
|31|Low phosphorylation of estrogen receptor alpha (ERalpha) serine 118 and high phosphorylation of ERalpha serine 167 improve survival in ER-positive breast cancer. (18550720)
Yamashita H.... Iwase H.
|32|Tamoxifen induces heparanase expression in estrogen receptor-positive breast cancer. (17634531)
Cohen I.... Elkin M.
|33|Estrogen receptor alpha (ER alpha) mRNA copy numbers in immunohistochemically ER alpha-positive-, and negative breast cancer tissues. (17391528)
Poola I.... Yue Q.
|34|An integrated analysis of genes and pathways exhibiting metabolic differences between estrogen receptor positive breast cancer cells. (17883861)
Mandal S.... Davie J.R.
|35|Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy. (17906205)
Bartlett J.M.... Ellis P.
|36|Estrogen receptor-beta: why may it influence clinical outcome in estrogen receptor-alpha positive breast cancer? (17617929)
|37|PARP regulates TGF-beta receptor type II expression in estrogen receptor-positive breast cancer cell lines. (16827122)
Sterling J.A.... Banerji S.S.
|38|The antitumor effect of LJ-529, a novel agonist to A3 adenosine receptor, in both estrogen receptor-positive and estrogen receptor-negative human breast cancers. (16546983)
Chung H.... Kong G.
|39|Is anthracycline-based chemotherapy alone adequate for young women with estrogen receptor-positive breast cancer? (16131469)
Papaldo P.... Cognetti F.
|40|Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer. (16809728)
Ring B.Z.... Ross D.T.
|41|Research review: Treatment of breast cancer with tamoxifen in older women with estrogen receptor-positive breast cancer: motivational issues. (15592256)
|42|HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study. (15355892)
Arpino G.... Elledge R.M.
|43|Heterogeneic expression of estrogen receptor between the primary tumor and the corresponding involved lymph nodes in patients with node-positive breast cancer and its implications in patient outcome. (12772201)
Iguchi C.... Itakura M.
|44|Modulation of epidermal growth factor receptor in endocrine-resistant, estrogen-receptor-positive breast cancer. (12095935)
Nicholson R.I.... Gee J.M.
|45|The role of Stat5 in estrogen receptor-positive breast cancer. (12459712)
Yamashita H.... Iwase H.
|46|A therapeutic target for hormone-independent estrogen receptor-positive breast cancers. (11474128)
Biswas D.K.... Pardee A.B.
|47|Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial. (11559718)
Ellis M.J.... Borgs M.
|48|Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer. (9816251)
Hui R.... Sutherland R.L.
|49|Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. (7861463)
Roodi N.... Parl F.F.
|50|Protein kinase C subspecies in estrogen receptor-positive and -negative human breast cancer cell lines. (2222428)
Bignon E.... Nishizuka Y.